Page 7 - Best MRI of one area doctors in Turkey: TOP 322 doctors

Prof. Dr. Yasef began his medical education at Istanbul University in 1973 and graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 1979. He started his specialization in neurology at the same university in 1980 and became a neurologist in 1985. During his specialty training, he spent 6 months at Hacettepe University in the Neurology Department in Ankara.

After becoming a neurologist, he completed 3.5 years of obligatory government service, spending the first 1.5 years at the Iskenderun Navy Hospital and the next 2 years at Diyarbakır Social Security Hospital. He returned to Istanbul University in 1989.

Prof. Dr. Yasef worked abroad in the United States from 1990 - 1991, focusing on dementia and behavioral neurology.

In 1994, he became an Associate Professor and continued working at Istanbul University until 1999. Between 1999 - 2002, he worked at Florence Nightingale Hospital, and then at Kozyatağı Acıbadem Hospital from 2004 to 2013.

Since 2013, he has been a valuable part of the team at Florence Nightingale Hospital.

Specialties

• Dementia
• Epilepsy
• Headaches

Work Experience

• Military Service at Iskenderun Navy Hospital, 1985 - 1986
• State Service at Diyarbakır S.S.K. Hospital, 1986 - 1989
• Florence Nightingale Hospital, 1999 - 2002
• Kozyatağı Acıbadem Hospital, 2004 - 2013
• Florence Nightingale Hospital (Since 2013)

Education and Expertise

GATA Military Medical Faculty

GATA Haydarpaşa Training Hospital Neurosurgery Clinic (Specialization)

Beykent University Hospital and Health Institutions Management (Master's)

Experience

GATA Military Medical Faculty Trainee Doctor (6 months)

Samsun Sahara Medical School Comm. (3 months)

Naval Command War Squadron TCG Diligence Medical Officer (2 years)

Dz.K.K. Submarine Battery Factory Infirmary Doctor (3 months)

Naval Forces Command Infirmary Doctor (3 months)

GATA Haydarpaşa Training Hospital Chief Assistant (12 years)

Kasımpaşa Marine Hospital Neurosurgery Clinic Chief (5 years)

Bahçelievler Medical Park Hospital Neurosurgery Specialist (11 years)

Altınbaş University Faculty of Medicine Neurosurgery Lecturer. Member (4 years)

Altınbaş University Faculty of Medicine Head of Neurosurgery Department. (3 years)

Basic and Advanced Cardiac life support courses (BASIC)

Basic and Advanced Cardiac life support courses (ADVANCED)

GATA Military Medical Faculty. Microsurgery Training Course

Istanbul Vatan Hospital Hand surgery microsurgery course

Neuroanatomy course

Spine Surgery course

Professional Memberships

Turkish Neurosurgery Association

Spine Society of Europe

Turkish Spinal and Peripheral Nerve Surgery Group

ACADEMIC CAREER SUMMARY

Degree: Bachelor's
Field: Medicine
University: Atatürk University
Year: 2001

Degree: Master's
Field: Medicine
University: Atatürk University
Year: 2001

Specialization/Doctorate: Internal Medicine/Gastroenterology
University: İnönü University
Year: 2012

Associate Professorship: Gastroenterology
University: İnönü University
Year: 2018

Foreign Language: English, 67.5, 2007

H-index (WoS/Google): 8/10

Impact Factor: 8.1577

Key Research Work:
“Does apocynin increase liver regeneration in the partial hepatectomy model?” Yılmaz Bilgiç, Burhan Hakan Kanat, Onural ÖZHAN, Azibe YILDIZ, Zeynep AKSUNGUR, Mehmet Erman ERDEMLİ, Nigar VARDI, Yusuf TÜRKÖZ, Sami AKBULUT, Adem KÖSE, Hakan PARLAKPINAR. Turkish Journal of Medical Sciences, 2023 (53), 1-12 Q3.

Declared Project Title, Year:
K.3.6. “Investigation of the Effects of Vinpocetine in Sepsis Created by Cecal Ligation and Puncture in Rats” (Principal Investigator), 2023

International Experience:
Advanced Endoscopy Training, Anam Hospital, South Korea (3 months, 2016)
Advanced ERCP Course, Olympus Training Center, Hamburg (2017)

ADMINISTRATIVE POSITIONS

• Institution: İnönü University Turgut Özal Medical Center
  City: Malatya
  Position: Assistant Chief Physician
  Period: 2021 - 2024

Dr. Semih Ak is an Orthopedics and Traumatology Specialist. He earned his MD from Yeditepe University Faculty of Medicine in Istanbul (2010–2016). He completed his residency at Istanbul Fatih Sultan Mehmet Training and Research Hospital (2017–2022).

He works as a specialist at Turan&Turan Musculoskeletal Health Center in Bursa (2025–present). He previously worked at Private Medicabil Hospital in Bursa (2024–2025) and at Artvin State Hospital as part of compulsory service (2022–2024). Earlier, he was a general practitioner at Ümraniye Training and Research Hospital (2017). He also worked at Sultanbeyli Community Health Center (2016).

Prof. Emin Tireli, MD, is a leading pediatric cardiovascular surgeon. He has performed over 6,329 congenital cardiac surgeries since 1993. He is known worldwide for being one of the first to use the complex Nikaidoh procedure for transposition of the great arteries (TGA).

Dr. Tireli performs more than 100 neonatal cardiac surgeries each year. His expertise includes arterial switch operations, total pulmonary return anomalies, pulmonary banding, and Norwood procedures. He has used hybrid techniques in 15 cases. Dr. Tireli has also completed 30 reconstructions of aortic anomalies and many PDA ligations in extremely low birth weight infants. His work greatly supports neonatal care.

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Education & Academic Qualifications

License (MD)

Field: Medicine

University: Istanbul University

Year: 1987

Residency

Field: Cardiovascular Surgery

Institution: Siyami Ersek Heart Center

Years: 1988–1994

Clinical Fellowship

Field: Cardiovascular Surgery

Institution: University of Ottawa Heart Center (Canada)

Years: 1994–1995

Academic Titles & Positions

Assistant Professor

Field: Cardiovascular Surgery

Institution: Siyami Ersek Heart Center

Years: 1995–2008

Professor

Field: Cardiovascular Surgery

Institution: Altınbaş University

Years: 2014–2019

Membership in Scientific and Professional Organizations

-Turkish Society of Cardiovascular Surgery

-European Society for Cardiovascular Surgery

-European Society for Vascular Surgery

1997 - 2002 Istanbul University Cerrahpaşa Faculty of Medicine, Department of Orthopedics and Traumatology

1990 - 1996 Istanbul University Cerrahpasa Faculty of Medicine

Articles he wrote and contributed to;

Clinical efficacy of peritendinous platelet-rich plasma injection in the treatment of tendinopathies: A retrospective study Aybars Kıvrak* (a), Mehmet Can Ünlü (a), Esref Terzi (a), Olgar Birsel (b), Doruk Akgun (c), Yusuf Pirincci (d), Gokhan Kaynak(a), Isik Akgun (e) Medium and long-term effects of acetabular roof ring and Burch-Schneider anti-protusio cages in acetabular revisions in patients with acetabular bone deficiency Correspondence: Yusuf Pirinççi , Muhammed Taha Demir, Mumammet Salih, Fahri Erdoğan, Nejat Güney

Dimensional variables of the proximal femur in developmental adult hip dysplasia suggest that a tapered, rectangular, press-fit design may be an optimal choice for patients with Crowe type IV hips

Specialties

Limb Lenghtening 

Sports Surgery

Meniscus Tears

Anterior Cruciate Ligament Tears

Knee Prosthesis

Hip Prosthesis

Shoulder Prosthesis

Shoulder Slap Repair

Height Extension

Tumor Surgery

Foot Surgery( Hallux Valgus)

Diabetic Foot

Bone Infections (Osteomyelitis)

Prof. İbrahim Azboy, M.D.

Languages: English, Kurdish, Arabic

Orthopaedics and Traumatology
 

Areas of Expertise and Interest

• Hip & knee arthroplasty (primary, revision, robotic‑assisted)
• Infection prevention & management in joint replacements
• Minimally invasive and joint‑preserving orthopedic surgery
• Sports & trauma-related injuries (e.g. ACL, fractures)
• Osteoarthritis, cartilage damage & osteonecrosis

International Researcher IDs:  

• ORCID: 0000-0003-0926-3029 / Yoksis Researcher ID: 145243 

Education & Training

• 1994–2001: Hacettepe University, Faculty of Medicine
• 2002–2008: Ministry of Health Istanbul Training and Research Hospital
• 2014 & 2017: Hospital for Special Surgery, New York, USA – Knee and Hip Arthroplasty and Arthroscopy Training
• 2016: Rothman Institute, Thomas Jefferson University, Philadelphia, USA – Knee and Hip Arthroplasty and Hip Preserving Surgery Training

Academic & Professional Appointments

• 2021–Present: Professor, Istanbul Medipol University
• 2017–2020: Associate Professor, Istanbul Medipol University
• 2011–2017: Assistant Professor, Dicle University
• 2008–2011: Consultant MD, Şanlıurfa and Balıkesir Military Hospitals

Professional Memberships

• Member of 9 national and international orthopedic associations including:
  AAHKS, SICOT, EHS, KADAD, TOTBID, TOTEK, and TTB

Scientific & Educational Contributions

• Prof. Dr. İbrahim Azboy has authored over 70 internationally and 25 nationally peer-reviewed journal articles, contributed to 4 book chapters and 2 book translations, and presented at 25+ international and 65+ national congresses. He also serves as a reviewer for 13 scientific journals, including JBJS, JOA, SICOT-J, and JORR.

Teaching & Speaking Engagements

• Speaker/trainer in 20+ national courses and congresses on topics such as:
• Hip and knee arthroplasty
• Prosthetic joint infections
• VTE prophylaxis
• Surgical approaches and implant strategies

Education and Specialization

1998 - Undergraduate (Medicine): Istanbul University Faculty of Medicine

2004 - Master’s Degree: Istanbul University Faculty of Medicine

2005 - 2011 - PhD (Urology): Taksim Training and Research Hospital

2020 - Associate Professor: Yeni Yüzyıl University

Experience

2011 to 2013 - Urology Specialist: Kastamonu Dr. Münif Islamoğlu State Hospital

2013 to 2014 - Urology Specialist: Izmir Private Marine Hospital

2014 to 2014 - Urology Specialist: Istanbul Murat Kölük State Hospital

2014 to 2016 - Urology Specialist: Gaziosmanpaşa Taksim Training and Research Hospital

2016 to 2020 - Faculty Member: Yeni Yüzyıl University Gaziosmanpaşa Hospital

2020 - Associate Professor: Yeni Yüzyıl University Gaziosmanpaşa Hospital

Articles Published in International Refereed Journals: A1

1)NUHOĞLU BARIŞ, BALCI MUSTAFA BAHADIR CAN, AYDIN MEMDUH, HAZAR İSMET, ONUK ÖZKAN, TAŞ TUNCAY, FİKRİ ONUR (2011). The Role of Bipolar Transurethral Vaporization in the Management of Benign Prostatic Hyperplasia. Urologia Internationalis.

2)BALCI MUSTAFA BAHADIR CAN, TAŞ TUNCAY, HAZAR İSMET, AYDIN MEMDUH, ONUK ÖZKAN, ÇAKIROĞLU BASRİ, INTELLECTUAL HONOR, ÖZKAN ARİF, NUHOĞLU BARIŞ (2014). Applicability and Effectiveness of Virtual Reality Simulator Training in Urologic Surgery: A Double-Blind Randomized Study. NOBEL MEDIUS.

3)ONUK ÖZKAN, TAŞ TUNCAY, ŞENTÜRK AB, ORHUN SINANOĞLU, BALCI MUSTAFA BAHADIR CAN, ÇELİK O, NUHOĞLU BARIŞ (2014). Right-Sided Bochdalek Hernia with Intrathoracic Ectopic Kidney in an Advanced-Age Adult: A Case Report. Urologia Internationalis.

4)ONUK ÖZKAN, BALCI MUSTAFA BAHADIR CAN, HAZAR İSMET, TAŞ TUNCAY, ÖZKAN ARİF, NUHOĞLU BARIŞ (2015). Giant Bladder Stone in a Young Woman. Journal of Academic Research in Medicine.

5)DİNÇER MUHAMMET MURAT, ONUK ÖZKAN (2015). Phalloplasty and Penile Prosthesis Implantation for Micropenis. Journal of Academic Research in Medicine

6)ONUK ÖZKAN, ARSLAN BURAK, HAZAR İSMET, ÖZKAN ARİF, ÇİLESİZ NUSRET CAN, NUHOĞLU BARIŞ (2016). Clinical Course of a Case with Sarcomatoid Renal Cell Carcinoma. International Journal of Medical and Pharmaceutical Research.

7)BALCI MUSTAFA BAHADIR CAN, ONUK ÖZKAN, HAZAR İSMET, ÖZKAN ARİF, ÇİLESİZ NUSRET CAN, ARSLAN BURAK, NUHOĞLU BARIŞ (2016). Incidental Prostate Cancer Frequency and Features of Patients Undergoing Radical Cystoprostatectomy. Journal of Academic Research in Medicine.

8)HİRİK ERKAN, BOZKURT ALİSEYDİ, KARABAKAN MEHMET, ONUK ÖZKAN, BALCI MUSTAFA BAHADIR CAN, AYDIN MEMDUH, ÇAKAN MURAT, NUHOĞLU BARIŞ (2016). Results of Tadalafil Treatment in Patients Following an Open Nerve-Sparing Radical Prostatectomy. Archivio Italiano di Urologia e Andrologia.

9)ARSLAN BURAK, AKBULUT MEHMET, ONUK ÖZKAN, HAZAR İSMET, ÖZKAN ARİF, GEZMİŞ CEM TUĞRUL, ÇETİN BUĞRA, AYDIN MEMDUH (2016). Risk Factors Affecting the Outcomes of Docetaxel-Prednisone Combination in the Treatment of Metastatic Castration-Resistant Prostate Cancer. British Journal of Medicine and Medical Research.

10)ONUK ÖZKAN, ARSLAN BURAK, YANARAL FATİH, HAZAR İSMET, ÖZKAN ARİF, GEZMİŞ TUĞRUL, NUHOĞLU BARIŞ (2016). Management of Gunshot Injury of Glans Penis that Extends to Anterior Urethra: A Rare Case Report. Haseki Medical Bulletin.

11)ARSLAN BURAK, AKBULUT MEHMET FATİH, ONUK ÖZKAN, KÜÇÜKTOPCU ONUR, ÇİLESİZ NUSRET CAN, ÖZKAN ARİF, YAZICI GÖKHAN (2017). A Comparison of Amplatz Dilators and Metal Dilators for Tract Dilatation in Mini-Minute Nephrolithotomy. International Urology and Nephrology.

12)ARSLAN BURAK, ONUK ÖZKAN, EROĞLU ALİ, GEZMİŞ TUĞRUL, AYDIN MEMDUH (2017). Female Sexual Function Follows a Novel Transobturator Sling Procedure without Paraurethral Dissection (Modified-TOT). International Braz J Urol.

13)ARSLAN BURAK, ONUK ÖZKAN, HAZAR İSMET, AYDIN MUAMMER, ÇİLESİZ NUSRET CAN, EROĞLU ALİ, NUHOĞLU BARIŞ (2017). Prognostic Value of Endocan in Prostate Cancer: Clinicopathologic Association Between Serum Endocan Levels and Biochemical Recurrence after Radical Prostatectomy. Tumori Journal.

14)ONUK ÖZKAN, ÇİSELİS NUSRET CAN, HAZAR İSMET, GÖZMÜŞ TUĞRUL, ÖZCANLI YUSUF TURUSHAN, DİNÇER MUHAMMET MURAT, NUHOĞLU BARIŞ (2016). Treatment of Giant Ureteral Fibroepithelial Polyp: A Case Report Using an Endoscopic Approach. Journal of Academic Research in Medicine.

15)YANARAL FATİH, BALCI MUSTAFA BAHADIR CAN, OZGÖR FARUK, ŞİMŞEK ABDULMUTALİP, ONUK ÖZKAN, AYDIN MUAMMER, NUHOĞLU BARIŞ (2017). Comparison of Conventional Dressings and Vacuum-Assisted Closure in the Wound Therapy of Fournier's Gangrene. Archivio Italiano di Urologia e Andrologia.

16)ONUK ÖZKAN (2018). A Minimally Invasive Modified Technique for Female Stress Urinary Incontinence: Transobturator Tape without Paraurethral Dissection. Videosurgery and Other Miniinvasive Techniques.

17)HAZAR İSMET, ONUK ÖZKAN, ÖZKAN ARİF, KIR GÜLAY, ÇİLESİZ NUSRET CAN, BALCI MUSTAFA BAHADIR CAN, NUHOĞLU BARIŞ (2018). Treatment of Primary Vesicovaginal Fistula Repair with Bladder Mucosal Flap: A Report of Initial Case Series. Journal of Academic Research in Medicine.

18)ONUK ÖZKAN, ARSLAN BURAK, GEZMİŞ TUĞRUL, ÇETİN BUĞRA, GÖV TAHA, YAZICI GÖKHAN, GÜRKAN OKAN, ÖZDEMİR ENVER (2018). Is the Plasma Endocan Level a Reliable Predictor for the Severity of Erectile Dysfunction?. International Urology and Nephrology.

19)ÖZKAN ARİF, ÇİLESİZ NUSRET CAN, KALKANLI ARİF, GÜNSEVEN KADIR ÖMÜR, ONUK ÖZKAN, HAZAR İSMET, BALCI MUSTAFA BAHADIR CAN (2018). Comparison of Local Anesthetic Efficacy of Lidocaine Gel and Lidocaine Gel-Intramuscular Diclofenac Combination in Patients Undergoing Flexible Cystoscopy. Journal of Academic Research in Medicine.

20)ARSLAN BURAK, GÖNÜLTAŞ SERKAN, GÖKMEN ERSİN, ÖZMAN OKTAY, ONUK ÖZKAN, YAZICI GÖKHAN, GÖV TAHA, ÖZDEMİR ENVER (2019). Does YouTube Include High-Quality Resources for Training on Laparoscopic and Robotic Radical Prostatectomy?. World Journal of Urology.

21)ONUK ÖZKAN, NUHOĞLU BARIŞ, ÖZKAN ARİF, TAŞ TUNCAY, ÇİLESİZ NUSRET CAN, HAZAR İSMET, BALCI MUSTAFA BAHADIR CAN (2019). Comparison of Caveolin-1 and PSA in Prostate Adenocarcinoma. Journal of Academic Research in Medicine.

22)ONUK ÖZKAN, ÖZKAN ARİF, ÇİLESİZ NUSRET CAN, KALKANLI ARİF (2019). Vacuum-Assisted Treatment in Fournier Gangrene. Journal of Academic Research in Medicine.

23)LOVMIS M, ONUK ÖZKAN, AKTAŞ S, ALKARA U, MERCİLESS O, LOVMIS S (2020). Two Renal Transplants From Living Donors With Horseshoe Kidneys. Urology.

24)ALİ EROĞLU, MUAMMER AYDIN, ÖZKAN ONUK, NUSRET CAN ÇİLESİZ, BARIŞ NUHOĞLU (2020). Investigation of Sexual Dysfunction in Premenopausal Women with Urinary Incontinence. Journal of Academic Research in Medicine.

25)TUNCAY TAŞ, BASRİ ÇAKIROĞLU, ERSAN ARDA, ÖZKAN ONUK, BARIŞ NUHOĞLU (2021). Early Clinical Results of the Tolerability, Safety, and Efficacy of Autologous Platelet-Rich Plasma Administration in Erectile Dysfunction. Sexual Medicine,.

26)ÖZKAN ONUK, NUSRET CAN ÇİLESİZ, ARİF ÖZKAN, ELBRUS ZARBALİYEV, NURTEN DAYIOĞLU, BARIŞ NUHOĞLU (2020). Urological Injuries in the Civil War of Libya.

Publications and articals goes on.

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

Dr. Mustafa Yavuz Samanci is an Associate Professor of Neurosurgery at Medipol Acıbadem District Hospital in Istanbul. He has specialized training in stereotactic, functional, and pediatric neurosurgery. Dr. Samanci completed a clinical fellowship in Gamma Knife Radiosurgery. He has also finished advanced programs in spinal cord and peripheral nerve stimulation. He received several TÜBİTAK postdoctoral research fellowships and the Prof. Dr. Hakan Caner Overseas Education Scholarship from the Turkish Neurosurgical Society.

Dr. Samanci is an active member of several national and international neurosurgical societies. These include the Turkish Neurosurgical Society, the International Parkinson and Movement Disorder Society, and the European Society for Stereotactic and Functional Neurosurgery. He has served on editorial boards and scientific committees. His work reflects significant contributions to academic neurosurgery and research.

Education and Expertise

1988: Istanbul University Cerrahpaşa Faculty of Medicine, Medical Education, Istanbul

1996: Haydarpaşa Numune Training and Research Hospital, Brain and Neurosurgery Clinic, Neurosurgery Specialist Training, Istanbul

Experience

1989 to 1996: Haydarpaşa Numune Training and Research Hospital, Brain and Neurosurgery Clinic, Assistant Doctor, Istanbul

1996 to 1999: Private Respect Hospital, Specialist Doctor and Chief Physician, Istanbul

2000 to 2002: Bakırköy Mental and Neurological Diseases Training and Research Hospital, 1st Neurosurgery Clinic, Specialist Doctor, Istanbul

2002 to 2010: Ministry of Health Pendik State Hospital, Specialist Doctor, Istanbul

2008 to 2009: Participation in "Spinal Surgery Program" at Istanbul American Hospital Neurosurgery Clinic. Fellowship Days: 01.05.2008 - 31.12.2009

2010 to 2011: University of California Los Angeles (UCLA), Santa Monica Hospital Center for Spinal Surgery (Comprehensive Spine Center), Researcher (Fellow), California, USA

2011: Associate Professor

2014: Virginia University Faculty of Medicine, Department of Brain and Neurosurgery, Visiting Faculty Member, Charlottesville, Virginia, USA

2012 to 2016: Istanbul Medeniyet University Faculty of Medicine, Department of Brain and Neurosurgery, Istanbul

2016 to 2018: Vital Fulya Plaza, Fulya/Beşiktaş/Istanbul

Professional Memberships

-Turkish Neurosurgery Association
-Turkish Neurosurgery Association, Spinal and Peripheral Nerve Surgery Teaching and Training Group
-Turkish Spine Association
-AO Spine International
-Society for Minimal Intervention in Spinal Surgery
-Turkish Neurosurgery Association, Surgical Neurosurgery Group
-Scoliosis Research Society (SRS)

 

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Education

• 1986-1989, Bursa High School, Bursa, Turkey
• 1989-1995, Istanbul University, Istanbul School of Medicine, Turkey
• 1999-2003, (Residency) Kadir Has University, School of Medicine, Department of Radiation Oncology, Istanbul, Turkey
• 2015, (Associate Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

Experience

• 1995-1999, Şişli Florence Nightingale Hospital, Istanbul, Cardiology Department
• 2003, Gayrettepe Florence Nightingale Hospital, Istanbul, Department of Radiation Oncology
• 2015, (Associate Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey